Quality Magazine - March 2009 - (Page 50) | QUA LIT Y M A N AG EM E N T | 3 Pfizer Chesterfield, MO From its modest beginnings in 1849, when cousins Charles Pfizer and Charles Erhart founded Charles Pfi zer & Co. in a red brick building in Brooklyn, NY, Pfi zer has grown into a household name as the world’s largest research-based biomedical and pharmaceutical company. Corporate Pfizer is the world’s largest researchbased biomedical and pharmaceutical company. Source: Pfizer Put More Muscle In Your Arm Only Verisurf Software intelligently manages all of your inspection devices with today’s most advanced, comprehensive suite of dynamic tools designed to save costly inspection and measurement time. Our common platform is revolutionizing manufacturing by providing powerful new capabilities from inspection to analysis, and reverse engineering. You will not believe how easy it is to learn and to use. Call today for a personal demonstration 1-888-713-7201 Quality Quick Clicks 421 at qualitymag.com Please visit us at WESTEC, Booth 3168 w w w. v e r i s u r f . c o m headquarters are in New York, with major research and development locations in the United States and England, including Groton and New London, CT; La Jolla, CA; St. Louis; Cambridge, MA; South San Francisco, CA; and Sandwich, England. In 2007, Pfi zer earned $48.4 billion in revenue and invested $8.1 billion in research and development, according to the company’s Web site. When addressing medicine, quality is paramount, and the company maintains the highest standards. Each day, approximately 85,000 colleagues in more than 150 countries work to discover, develop, manufacture and deliver quality, safe and effective prescription medicines to patients. “To ensure that we deliver the value our patients and customers need and our shareholders deserve, we are focused on continually improving the way we do business; on operating with transparency in everything we do; and on listening to the views of all of the people involved in health care decisions,” says the company. In late January, Pfizer and pharmaceutical company Wyeth (Madison, NJ) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Wyeth in a cash-andstock transaction. The combined company will create one of the most diversified companies in the global health care industry, with product offerings in numerous growing therapeutic areas, a strong product pipeline and leading scientific and manufacturing capabilities, according to Pfizer’s Web site. For more information, visit www.pfizer.com. 50 QUALITY | March 2009 www.qualitymag.com http://www.verisurf.com http://www.verisurf.com http://www.pfizer.com http://www.qualitymag.com http://www.qualitymag.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.